CD274 and neoplasm: Testing different cut-offs of PD-L1 expression in association with patient survival showed differences by trend in none vs any PD-L1 expression, and even more significant results using the cut-off of > 5% PD-L1-positive tumor cells, while all other pre-selected cut-offs were not statistically significant (Additional file 2: Table S1).